Implantable Defibrillators (Implantable Cardioverter-Defibrillator)

Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.
Also Known As:
Implantable Cardioverter-Defibrillator; Defibrillators, Implantable; Cardioverter Defibrillators, Implantable; Cardioverter-Defibrillator, Implantable; Defibrillator, Implantable; Implantable Cardioverter Defibrillators; Implantable Defibrillator; Cardioverter-Defibrillators, Implantable; Implantable Cardioverter-Defibrillators
Networked: 4249 relevant articles (286 outcomes, 651 trials/studies)

Relationship Network

Therapy Context: Research Results


1. Moss, Arthur J: 65 articles (12/2015 - 04/2003)
2. Zareba, Wojciech: 59 articles (12/2015 - 04/2003)
3. McNitt, Scott: 47 articles (10/2015 - 10/2004)
4. Al-Khatib, Sana M: 36 articles (12/2015 - 05/2004)
5. Dorian, Paul: 33 articles (09/2015 - 05/2003)
6. Goldenberg, Ilan: 32 articles (12/2015 - 05/2006)
7. Friedman, Paul A: 31 articles (02/2015 - 04/2002)
8. Gold, Michael R: 30 articles (07/2015 - 01/2002)
9. Bardy, Gust H: 29 articles (07/2014 - 01/2005)
10. Maron, Barry J: 28 articles (09/2015 - 03/2002)

Related Diseases

1. Cardiac Sudden Death (Sudden Cardiac Arrest)
2. Sudden Death
3. Heart Failure
11/15/2014 - "In conclusion, cardiac resynchronization therapy in combination with an implantable cardioverter-defibrillator resulted in improved survival among Medicare patients meeting class I criteria and most patients meeting class IIa criteria as outlined in the current guidelines for device-based therapy in heart failure, although the effect sizes were lower than those demonstrated in recent trials."
11/01/2013 - "The Resynchronization-Defibrillation for Ambulatory Heart Failure Trial showed that implantable cardioverter defibrillator-CRT was associated with a significant reduction in the primary end point of all-cause mortality or heart failure hospitalization. "
10/01/2012 - "In patients with an implantable defibrillator, remote monitoring is effective in identifying device malfunctioning and clinical problems, such as heart failure, to an extent similar to traditional ambulatory monitoring, while allowing significant advantages for the patient quality of life and savings in resource management. "
02/01/2012 - "IMPROVE HF, a 24-month performance improvement initiative for outpatient cardiology and multispecialty practices, demonstrated significant improvement in guideline-based use of implantable cardioverter-defibrillators (ICDs) for patients with heart failure (HF). "
03/01/2008 - "The SCD-HeFT demonstrated that implantable cardioverter/defibrillator (ICD) therapy significantly improved survival compared to medical therapy alone in stable moderately symptomatic heart failure patients with an ejection fraction < or = 35%. "
4. Ventricular Tachycardia
5. Tachycardia (Tachyarrhythmias)

Related Drugs and Biologics

1. Amiodarone (Amiodarona)
2. Adenosine Triphosphate (ATP)
3. Angiotensins
4. Anti-Arrhythmia Agents
5. Sotalol (Sotalol Hydrochloride)
6. Aldosterone
7. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
8. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
9. Quinidine (Chinidin)
10. Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)

Related Therapies and Procedures

1. Cardiac Resynchronization Therapy
2. Defibrillators (Defibrillator)
3. Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
4. Drug Therapy (Chemotherapy)
5. Transplantation (Transplant Recipients)